raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:420611

Transient myeloproliferative syndrome

Synonyms: Transient myeloproliferative disease · TMD · Transient abnormal myelopoiesis

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Antenatal, Neonatal
Status
active

A rare hematologic disease characterized by clinical and morphological findings indistinguishable from those of acute myeloid leukemia, typically occurring in newborns with Down syndrome. Peripheral blood and bone marrow blasts display features suggestive of megakaryoblasts. In addition to trisomy 21, acquired GATA1 mutations are present in blast cells. Patients may be asymptomatic or present with thrombocytopenia, less commonly other cytopenias, leukocytosis, hepatosplenomegaly, jaundice, ascites, respiratory distress, bleeding, and pericardial or pleural effusions. Most patients undergo spontaneous remission within the first three months of life, although some may develop life-threatening hepatic, renal, or cardiac complications.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enTransient myeloproliferative syndromeTransient myeloproliferative disease · TMD · Transient abnormal myelopoiesis
frSyndrome myéloprolifératif transitoireMMT · Maladie myéloproliférative transitoire · Myélopoïèse transitoire anormale · TMD
deTransientes myeloproliferatives SyndromTMD · Transiente abnormale Myelopoese · Transiente myeloproliferative Krankheit
esSíndrome mieloproliferativo transitorioEnfermedad mieloproliferativa transitoria · Mielopoyesis anómala transitoria · SMT
itSindrome mieloproliferativa transitoriaMalattia mieloproliferativa transitoria · Mielopoiesi anomala transitoria · TMD
nlVoorbijgaand myeloproliferatief syndroomTMD · Voorbijgaande abnormale myelopoëse · Voorbijgaande myeloproliferatieve ziekte
ptSíndrome meloproliferativo transitório
plPrzejściowy zespół mieloproliferacyjnyPrzejściowa choroba mieloproliferacyjna · Przejściowa nieprawidłowa mielopoeza · TMD
csTranzientní myeloproliferativní syndromTMD · Tranzientní abnormální myelopoéza · Tranzientní myeloproliferativní choroba
ukТранзиторний мієлопроліферативний синдромTMD · Транзиторний аномальний мієлопоез · Транзиторна мієлопроліферативна хвороба
zh一过性骨髓增生综合征一过性骨髓增生性疾病
trGeçici miyeloproliferatif sendromTMD · Geçici anormal miyelopoezis · Geçici miyeloproliferatif hastalık

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM159595Evalidated
ICD-10D47.1NTBTattributedvalidated
ICD-112A60.40Especificvalidated
MONDO0008040Evalidated
MeSHC563551Evalidated
UMLSC1834582Evalidated
GARD12765Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
GATA1Disease-causing somatic mutation(s) inAssessedHGNC:4170ENSG00000102145305371Xp11.23GATA binding protein 114636651[PMID]
5

Prevalence and incidence

0 records

No prevalence record in this release.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card